These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31722915)

  • 1. Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.
    Kamrul R; Bunka D; Crawley A; Schuster B; LeBras M
    Can Fam Physician; 2019 Nov; 65(11):807-811. PubMed ID: 31722915
    [No Abstract]   [Full Text] [Related]  

  • 2. In patients with chronic neuropathic pain, cannabinoids improve sleep and reduce pain vs. placebo.
    Kim J
    Ann Intern Med; 2023 May; 176(5):JC57. PubMed ID: 37126815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Commentary: Cannabinoid Dosing for Chronic Pain Management.
    Boehnke KF; Clauw DJ
    Ann Intern Med; 2019 Jan; 170(2):118. PubMed ID: 30615778
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic and non-neuropathic chronic pain at GP encounters: Prevalence, patient characteristics, suffering and pregabalin use.
    Henderson J; Pollack AJ; Pan Y; Miller GC
    Aust Fam Physician; 2016 Nov; 45(11):783-786. PubMed ID: 27806445
    [No Abstract]   [Full Text] [Related]  

  • 6. Are cannabinoids effective for orofacial pain states?
    Sessle BJ
    J Oral Facial Pain Headache; 2015; 29(1):5-6. PubMed ID: 25715439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
    Petzke F; Enax-Krumova EK; Häuser W
    Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cannabinoids in pain control: the good, the bad, and the ugly.
    Pergolizzi JV; Lequang JA; Taylor R; Raffa RB; Colucci D;
    Minerva Anestesiol; 2018 Aug; 84(8):955-969. PubMed ID: 29338150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
    Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
    Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabinoids for the treatment of chronic pain - an overview of current medical knowledge].
    Gras-Ozimek J; Kozińska U; Gras-Ozimek A
    Pol Merkur Lekarski; 2022 Aug; 50(298):257-261. PubMed ID: 36086988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective is ketamine in the management of chronic neuropathic pain?
    Shteamer JW; Callaway MA; Patel P; Singh V
    Pain Manag; 2019 Nov; 9(6):517-519. PubMed ID: 31613180
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabis for Symptom Management in Older Adults.
    Levy C; Galenbeck E; Magid K
    Med Clin North Am; 2020 May; 104(3):471-489. PubMed ID: 32312410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Frequency Spinal Cord Stimulation at 10 kHz for the Treatment of Chronic Neuropathic Pain After a II-III Degree Burn.
    Steinbach K; Bettstetter H; Link C
    Pain Med; 2017 Sep; 18(9):1826-1828. PubMed ID: 28371858
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of chronic neuropathic pain of different causes with the combination of oral methadone along with ketamine: A report of 18 cases.
    de Godoy MC; Dalmolin GD; Rigo FK; Rossato MF; de Menezes MS; Alvarez MA; Hernandes JJ; Moreno LA; Sinche M; Ferreira J
    Eur J Anaesthesiol; 2013 Oct; 30(10):638-40. PubMed ID: 23624745
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of antineuropathic medications for the treatment of chronic pain.
    Urits I; Li N; Berardino K; Artounian KA; Bandi P; Jung JW; Kaye RJ; Manchikanti L; Kaye AM; Simopoulos T; Kaye AD; Torres M; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):493-506. PubMed ID: 33004161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Briner A; Schneider T
    Ther Umsch; 2017; 74(5):261-266. PubMed ID: 29083285
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic pain and cannabinoids. Great expectations or a christmas carol.
    Pascual D; Sánchez-Robles EM; García MM; Goicoechea C
    Biochem Pharmacol; 2018 Nov; 157():33-42. PubMed ID: 30056139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review.
    Viswanath O; Urits I; Jones MR; Peck JM; Kochanski J; Hasegawa M; Anyama B; Kaye AD
    Curr Pain Headache Rep; 2019 May; 23(6):37. PubMed ID: 31044330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dorsal Column Stimulation and Cannabinoids in the Treatment of Chronic Nociceptive and Neuropathic Pain: a Review of the Clinical and Pre-clinical Data.
    Odonkor CA; AlFarra T; Adekoya P; Orhurhu V; Rodríguez T; Sottosanti E; Kaye AD
    Curr Pain Headache Rep; 2022 Feb; 26(2):103-118. PubMed ID: 35119602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.